跳至主要内容
临床试验/IRCT20180814040795N2
IRCT20180814040795N2招募中3 期

A comparative study on the effects of oral N-acetylcystein and Pregabalin on the blood level of oxidative stress biomarkers in patients with painful diabetic neuropathy: adouble_blinde randomized clinical trial.

Hamedan University of Medical Sciences0 个研究点目标入组 140 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 70 years(—)
性别
All

入选标准

  • Age 30 to 70 years old
  • History of type 2 Diabetes mellitus at least one year ago
  • Hemoglobine A1C Less than or equal to 9
  • Diabetic neuropathy with NDS(Neuropathy Disablity Score) greater than or equal to 6, VAS(Visual analogue scale)fore pain at least 4 and NSS(Neuropathy symptom score) greater than or equal to 5
  • glomerular filtration rate more than 30 cc/min

排除标准

  • Type 1 diabetes
  • pregnancy or breastfeeding
  • Diabetic foot ulcer
  • neuropathy for reasons other than diabetes
  • History of cerebrovascular disease and discopathy
  • Use other medications to relieve symptoms of neuropathy
  • Use of alcoholic drink or opioids

研究者

相似试验

A comparative study on the effects of oral... | 临床试验